Mouse mammary tumor virus and mammary tumorigenesis in wild mice

Pathology International

Volumn 46, Issue 12, 1996, Pages 919-932

  Imai, Shunsuke ^a,b  

^a Nara Prefectural Institute of Public Health   (Japan)

^b Nara Prefectural Institute of Public Health   (Japan)

Author keywords

animal models; breast cancer; mammary tumorigenesis; mouse mammary tumor virus

Indexed keywords

DNA;

ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER MODEL; FEMALE; GENE SEQUENCE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; STRAIN DIFFERENCE; VIRUS CARCINOGENESIS; VIRUS GENOME;

EID: 0030476721     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03570.x     Document Type: Review

References (136)

1. Klein J. ed. Biology of the Mouse Histocompatibility-2 Complex. Springer-Verlag, Berlin, 1975.
2. Heston WE, Vlahakis G. Genetic factors in mammary tumorigenesis. In: Carcinogenesis: A Broad Critique. Williams and Wilkins, Baltimore, 1967; 347-363.
3. Staff of the Roscoe B. Jackson Memorial Laboratory. The existence of nonchromosomal influence in the incidence of mammary tumors in mice. Science 1933; 78: 465-466.
4. Korteweg R. Proefondervindelijke onderzoekingen aangaande erfelijkhjeid van kanker. Ned. Tijdschr. Geneeskd 1934; 78: 240-245 (in Dutch).
5. Gross L. Oncogenic Viruses, 2nd edn. Pergamon Press, London, 1970.
6. Green EL. Biology of the Laboratory Mouse. McGraw-Hill, New York, 1966.
7. Bittner JJ. Some possible effects of nursing on the mammary tumor incidence in mice. Science 1936; 84: 162.
8. Hilgers J, Bentvelzen P. Interaction between viral and genetic factors in murine mammary cancer. Adv. Cancer Res. 1978; 26: 143-195.
9. Cohen JC, Varmus HE. Endogenous mammary tumor virus DNA varies among wild mice and segregates during inbreeding. Nature 1974; 278: 418-423.
10. Nandi S, McGrath CM. Mammary neoplasia in mice. Adv. Cancer Res. 1973; 17: 353-414.
11. Varmus HE, Bishop JM, Nowinski RC, Sarkar NH. Mammary tumor virus specific nucleotide sequences in mouse DNA. Nature (London) 1972; 238: 189-191.
12. Moriwaki K, Shiroishi T, Yonekawa H. Genetics in Wild Mice. Karger Japan Scientific Societies Press, 1995.
13. Rongey RW, Hlavackoa A, Lara S, Estes J, Gardner MB. Types B and C RNA virus in breast tissue and milk of wild mice. J. Natl Cancer Inst. 1973; 50: 1581-1589.
14. Rongey RW, Abtin AG, Estes JD, Gardner MB. Mammary tumor virus particles in the submaxillary gland, seminal vesicle, and non-mammary tumor of wild mice. J. Natl Cancer Inst. 1975; 54: 1149-1156.
15. Callahan R, Drohan W, Gallahan D, D'Hoostelaere L, Potter M. Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome. Proc. Natl Acad. Sci. USA 1982; 79: 4113-4117.
16. Callahan R, Gallahan D, D'Hoostelaere LA, Potter M. Endogenous MMTV proviral genomes in feral Mus musculus domesticus. Curr. Top Microbiol. Immunol. 1986; 127: 362-370.
17. Dmochowski L. A biological and biophysiological approach to the study of the development of mammary cancer in mice. Acta Unio Int. Contra Cancerum 1956; 12: 582-618.
18. Blair PB. The mammary tumor virus (MTV). Top. Microbiol. Immunol. 1956; 45: 1-69.
19. Hageman P, Calafat J, Daams JH. The mouse mammary tumor viruses. In: Emmelot P, Bentvelzen P, eds. RNA Viruses and Host Genome in Oncogenesis. North-Holland Publishing Company, Amsterdam, 1971, 283-300.
20. Bentvelzen P. Tumor viruses. In: Kurstak E, Maramorosch K, eds. Viruses Evolution and Cancer. Academic Press, New York, 1974; 279-367.
21. Bonhomme F, Guenet JL. Origins of Mouse Inbred Strains. Saunders Scientific Publications, London, 1991; 1108-1110.
22. Yonekawa H, Moriwaki K, Gotoh O et al. Evolutionary relationships among five subspecies of Mus musculus based on restriction enzyme cleavage patterns of mitochondrial DNA. Genetics 1981; 98: 801-816.
23. Anderront HB, Dunn TB. Occurrence of tumors in wild house mice. J. Natl Cancer Inst. 1962; 28: 1153-1163.
24. Imai S, Okumoto M, Iwai M et al. Distribution of mouse mammary tumor virus in Asian wild mice. J. Virology 1994; 68: 3437-3442.
25. Dunn TB. Morphology of mammary tumors in mice. In: Homburger F, ed. Physiopathology of Cancer, 2nd edn. Hoeber, New York, 1959; 38.
26. Sass B, Dunn TB. Classification of mouse mammary tumors in Dunn's miscellaneous group including recently reported types. J. Natl Cancer Inst. 1979; 62: 1287-1293.
27. Blair PB, Lane MA. Immunologic evidence for horizontal transmission of MTV. J. Immunol. 1974; 113: 1446-1449.
28. Lopez DM, Ortismuniz G, Sigel MM. Macrophage migration inhibition and lymphocyte stimulation with mammary tumor virus associated antigens in BALB/C mice. Proc. Soc. Exp. Biol. Med. 1976; 151: 225-230.
29. Pogossiantz H. Some data on the experimental studies on the nature of mammary cancer in mice carried out in the Soviet Union. Acta Unio Int. Contra Cancerum 1956; 12: 690-700.
30. Bentvelzen P, Brinkhof J. Organ distribution of exogenous murine mammary tumor virus as determined by bioassay. Eur. J. Cancer 1977; 13: 241-245.
31. Imai S, Morimoto J, Tsubura Y et al. Tissue and organ distribution of mammary tumor virus antigens in low and high mammary cancer strain mice. Eur. J. Cancer 1983; 19: 1011-1019.
32. Hilgers J, Nowinski RC, Geering G, Hardy M. Detection of avian and mammalian oncogenic RNA viruses (oncorna viruses) by immunofluorescence. Cancer Res. 1972; 32: 98-106.
33. Hilgers J, Theuns GJ, Van Nie R. Mammary tumor antigen in normal and mammary tumor bearing mice. Int. J. Cancer 1973; 12: 568-576.
34. Kozma S, Calberg-Bacq CM, Francois C, Osterreich PM. Detection of viral antigens in Swiss albino mice infected by milk-borne mouse mammary tumor virus: effect of age, sex and reproductive status. I. Localization of immunofluorescence of tumor antigen in mammary tissues and other organs. J. Gen. Virol. 1979; 45: 27-40.
35. Morimoto J, Imai S, Tsubura Y, Hilgers J. Horizontal transmission of the mouse mammary tumor virus in cage mates of the same and opposite sex of low and high mammary cancer strain mice. Exp. Anim. 1985; 34: 141-146.
36. Schlom J, Hand PH, Teramoto YA, Callahan R, Todaro G, Schiidlovsky G. Characterization of a new virus from Mus cervicolar immunologically related to the mouse mammary tumor virus. J. Natl Cancer Inst. 1978; 61: 1509-1515.
37. Horan-Hand P, Teramoto YA, Callahan R, Schlom J. Interspecies radioimmunoassay for the major internal protein of mammary tumor viruses. Virology 1980; 101: 61-71.
38. Teramoto YA, Hand PH, Callahan R, Schlom J. Detection of novel murine mammary tumor viruses by interspecies immunoassays. J. Natl Cancer Inst. 1980; 64: 967-975.
39. Colcher D, Horan-Hand P, Teramoto YA, Wunderlich D, Schlom J. Use of monoclonal antibodies to define the diversity of the genus. Mus. Cancer Res. 1981 ; 41: 1451-1459.
40. Massay RJ, Arthur LO, Nowinski RC, Schochetman G. Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity. J. Virol. 1980; 34: 635-643.
41. Imai S, Hilgers J. Levels of mammary tumor virus proteins (MTVp27 and MRVgp52) in the milk of low and high mammary cancer mouse strains of Japanese origin compared with European and American strains. Int. J. Cancer 1979; 24: 359-364.
42. Morimoto J. Production and properties of monoclonal antibodies against mouse mammary tumor virus (DD-MMTV) with special reference to horizontal transmission of MMTV. J. Nara Med. Assoc. 1987; 38: 501-516.
43. Tsubura A, Inada M, Imai S et al. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vitro. Cancer Res. 1988; 48: 6555-6559.
44. Nandi S, DeOme KB, Handin M. Mammary tumor virus activity in blood and mammary tissues of C3H and Balb/cfC3H strains of mice. J. Natl Cancer Inst. 1965; 35: 309-318.
45. Nandi S, Haslam S. Localization of mammary tumor virus inside red blood cells of mice. Cancer Res. 1971; 31: 479-481.
46. Nandi S, McGrath CM. Mammary neoplasia in mice. Adv. Cancer Res. 1973; 17: 353-414.
47. Hageman P, Calafat J, Daams JH. The mouse mammary tumor viruses. In: Emmelot P, Bentvelzen P, eds. RNA Viruses and Host Genome in Oncogenesis. North Holland, Amsterdam, 1972; 283-300.
48. Festenstein H. Immunologic and biological aspects of in vitro allotransformation (MLR) in the mouse. Transplant. Rev. 1973; 15: 62.
49. Woodland DL, Lund FE, Happ MP, Blackman MA, Palmer E, Cortey RB. Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci. J. Exp. Med. 1991; 174: 1255.
50. Acha-Orbea H, Shakhov AN, Scarpellino L et al. Clonal deletion of Vβ14 positive T cells in mammary tumor virus transgenic mice. Nature 1991; 350: 207-211.
51. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumor virus genomes. Nature 1991; 349: 529-531.
52. Frankel WN, Rudy C, Coffin JM, Huber BT. Linkage of MIs genes to endogenous mammary tumor viruses of inbred mice. Nature 1991; 349: 526-528.
53. Woodland DL, Happ MP, Gollub KJ, Palmer E. An endogenous retrovirus mediating deletion of AB T cells? Nature 1991; 349: 529-531.
54. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 1991; 350: 203-207.
55. Huber B. MIs genes and self-superantigen. Trends Biochem. Sci. 1992; 8: 399-402.
56. Held W, Shakhov AN, Waanders G et al. An exogenous mouse mammary tumor virus with properties of MIs-1 (Mtv-7). J. Exp. Med. 1992; 175: 1623-1633.
57. Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, Acha-Orbea H. New infectious mammary tumor virus superantigen with Vβ-specificity identical to staphylococcal enterotoxin B (SEB). Eur. J. Immunol. 1994; 24: 1757-1764.
58. Ringold GM, Blari PB, Bishop JM, Varmus HE. Nucleotide sequence homologies among mouse mammary tumor viruses. Virology 1976; 70: 550-553.
59. Zeilmaker GH. Transmission of mammary tumor virus by female GR mice: Results of egg transplantation. Int. J. Cancer 1969; 4: 261-266.
60. Brookes S, Placzek M, Moore R, Dixon M, Dickson C, Peter G. Insertion elements and transitions in cloned mouse mammary tumor virus DNA: Further delineation of the poison sequence. Nucl. Acid. Res. 1986; 14: 8231-8245.
61. Donehower LA, Anfre J, NBerard DS, Wolford RG, Hager GL. Construction and characterisation of molecular clones containing integrated mouse mammary virus sequences. Cold Spring Harbor Symp. Quant. Biol. 1980; 44: 1153-1159.
62. Groner B, Buetti E, Diggelmann H, Hynes NH. Characterization of endogenous and exogenous mouse mammary tumor virus proviral DNA with site-specific molecular clones. J. Virol. 1980; 36: 734-745.
63. Donehower LA, Haung AL, Hager GL. Regulatory and coding potential of the mouse mammary tumor virus long terminal redundancy. J. Virol. 1981; 37: 226-238.
64. Majors JE, Varmus HE. Nucleotide sequencing at host-proviral junctions for mouse mammary tumor virus. Nature 1981; 289: 253-258.
65. Ucker DS, Ross SR, Yamamoto KR. Mammary tumor virus DNA contains sequences required for its hormone-regulated transcription. Cell 1981; 27: 257-266.
66. Fasel N, Buetti E, Firzlaff J, Pearson K, Diggelman H. Nucleotide sequence of the 5′ noncoding region and part of the gag gene of mouse mammary tumor virus: Identification of the 5′ splicing site for subgenomic mRNAs. Nucl. Acids Res. 1983: 11: 6943-6955.
67. Majors JE, Varmus HE. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gen. J. Vriol. 1983; 47: 495-504.
68. Peterson DO, Kriz KG, Marich JE, Toohey MG. Sequence organization and molecular cloning of mouse mammary tumor virus DNA endogenous to C57BL/6 mice. J. Virol. 1985; 54: 521-531.
69. Xu L, Haga S, Imai S. Cloning in a plasmid of an MMTV from a wild Chinese mouse: Sequencing of the viral LTR. Virus Res. 1994; 33: 167-178.
70. Nishio M, Xu L, Sasaki M et al. Complete nucleotide sequence of mouse mammary tumor virus from JYG Chinese wild mice: Absence of bacterial insertion sequences in the cloned gag gene, Breast Cancer 1994; 1: 89-94.
71. Etkind RR, Szabo P, Sarkar NH. Restriction endonuclease mapping of the proviral DNA of the exogenous RIII murine mammary tumor virus. J. Virol. 1982; 41: 855-867.
72. Shackleford G, Varmus H. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus and a derivative genetic vector. Proc. Natl Acad. Sci. USA 1988; 85: 9655-9659.
73. Morris DW, Bradshaw HD, Billy HT, Munn R, Cardiff RD. Isolation of a pathogenic clone of mouse mammary tumor virus. J. Virol. 1989; 63: 148-158.
74. Gallahan D, Callahan R. Mammary tumorigenesis in feral mice: Identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J. Virol. 1987; 61: 66-74.
75. Dalton AJ, Heine VI, Melnick JL. Characterization of oncornaviruses and related viruses: A report (Symposium). J. Natl Cancer Inst. 1975; 55: 941-943.
76. Bernhard W. Electron microscopy of tumor cells and tumor viruses: A review. Cancer Res. 1958; 18: 491-509.
77. Tanaka H, Tamura A, Tsujimura D. Properties of the intracytoplasmic A particles purified from mouse tumors. Virology 1972; 49: 61-78.
78. Sarkar NH, Whittington ES. Identification of the structural proteins of the murine mammary tumor virus that are serologically related to the antigens of intracytoplasmic type A particles. Virology 1977; 81: 91-106.
79. Cardiff RD, Puentes HJ, Young LJT et al. Serological and biochemical characterization of the mouse mammary tumor virus with localization of p10. Virology 1978; 85: 157-167.
80. Callahan R, Benveniste RE, Sherr CJ, Schildlovsky G, Todaro GJ. A new class of genetically transmitted retrovirus isolated from Mus cervicolar. Proc. Natl Acad. Sci. USA 1976; 73: 3579-3583.
81. Sarkar NH. Oncovirinae: Type B oncovirus. In: Nermut MV, Steven AC, eds. Perspectives in Medical Virology (Animal Virus structure). Elsevier, New York, 1987; 257-272.
82. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31: 99-109.
83. Nusse R. The activation of cellular oncogenes by retroviral insertion. Trends Genet. 1986; 2: 244-247.
84. Dickson C, Peters G. Protein-coding potential of mouse mammary tumor virus. Curr. Top. Microbiol. Immunol. 1983; 106: 1-35.
85. Peters G, Brookes S, Smith R, Dickson C. Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors. Cell 1983; 33: 369-377.
86. Nusse R, Brown A, Papkoff J et al. A new nomenclature for int-1 and related genes: The Wnt gene family. Cell 1991; 64: 231.
87. Hayward WS, Neel BG, Astrin SM. Activation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1981; 290: 475-480.
88. van Lohuizen M, Berns A. Tumorigenesis by slow-transforming retroviruses: an update. Biochim. Biophys. Acta 1990; 1032: 213-235.
89. Dickson C, Smith R, Brooks S, Peters G. Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2. Cell 1984; 37: 529-536.
90. Peters G, Brookes S, Smith R, Placzek, Dickson C. The mouse homolog of the hist/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc. Natl Acad. Sci. USA 1989; 86: 5678-5682.
91. Roelink H, Wagenar E, Lopes da Silva S, Nusse R. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and normally expressed in mouse embryos and adult brain. Proc. Natl Acad. Sci. USA 1990; 87: 4519-4523.
92. Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: A member of the notch gene family transforms mammary epithelial cells. J. Virol. 1992; 66: 2594-2599.
93. Peters G, Lee AE, Dickson C. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumor virus. Nature 1986; 320: 628-631.
94. Mester J, Wagenaar E, Sluyser M, Nusse R. Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice. J. Virol. 1987; 61: 1073-1078.
95. Roelink H, Wagenaar E, Nusse R. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 1992; 7: 487-492.
96. Gallahan D, Escot C, Hogg E, Callahan R. Mammary tumorigenesis in feral species of the genus Mus. Curr. Top. Microbiol. Immunol. 1986; 127: 354-361.
97. Varmus HE. The molecular genetics of cellular oncogenes. Annu. Rev. Genet. 1984; 18: 533-612.
98. O'Brien SJ. Genetic Maps. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1984.
99. Sarkar NH, Haga S, Lehner AF, Zhao W, Imai S, Moriwaki K. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: Normaland tumor-tissue-specific expression of int-3 transcripts. Virology 1994; 203: 52-62.
100. Nusse R, van Ooyen A, Cox D, Fung YKT, Varmus H. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 1991; 307: 131-136.
101. Pathak VK, Strange R, Young LJT, Morris DW, Cardiff RD. Survey of int region DNA rearrangements in C3H and Balb/ cf C3H mouse mammary tumor system. J. Natl Cancer Inst. 1987; 78: 327-331.
102. Dickson C. Molecular aspects of mouse mammary tumor virus biology. Int. Rev. Cytol. 1987; 108: 119-147.
103. Marchetti A, Robbins J, Campbell G et al. Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. J. Virol. 1991; 65: 4550-4554.
104. Henderson BE, Powell D, Rosario I et al. An epidemiologic study of breast cancer. J. Natl Cancer Inst. 1971; 53: 609-614.
105. Pimentel E. Human oncovirology. Biochim. Biophys. Acta 1979; 560: 169-216.
106. Charney J, Moore DH. Neutralization of murine mammary tumor virus by sera of women with breast cancer. Nature 1971; 229: 627-628.
107. Newgard DW, Cardiff RD, Blair PB. Human antibodies binding to the mouse mammary tumor virus: A non specific reaction? Cancer Res. 1976; 36: 765-768.
108. Schlom J, Spiegelman S, Moore D. Detection of high-molecularweight RNA in particles from human milk. Science 1972; 175: 542-544.
109. Mesa-Tejada R, Keydar I, Ramanarayaman M, Ohno T, Fenoglio C, Spiegelman S. Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Proc. Natl Acad. Sci. USA 1978; 75: 1529-1533.
110. Levine P, Mourali N, Tabbave F et al. Immunopathologic features of rapidly progressing breast cancer (RPBC) in Tunisia. Proc. Am. Assoc. Cancer Res. 1980; 21: 170.
111. Lloyd R, Rosen PP, Sarkar NH et al. Murine mammary tumor virus related antigen in human male mammary carcinoma. Cancer 1983; 51: 654-661.
112. Livinov SY, Oolovkina TV. Expression of proteins immunologically related to murine mammary tumor virus (MMTV) core proteins in the cells of breast cancer continuous lines MCF-7, T47D,MDA-231 and cells from human milk. Acta Virol. 1989; 33: 137-142.
113. Zotter S, Kemmer C, Losnitzer A, Grossmann H, Johannsen BA. Mouse mammary tumor virus-related antigens in core-like density fractions from large samples of women's milk. Eur. J. Cancer 1980; 16: 455-467.
114. Day NK, Witkin SS, Sarkar NH, Kinne D, Jussuwalla DJ. Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: Geographic and family studies. Proc. Natl Acad. Sci. USA 1981; 78: 2483-2487.
115. Witkin SS, Sarkar NH, Kinne DW, Breed CN, Good RA, Day NK. Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids. J. Clin. Invest. 1981; 67: 216-222.
116. Keydar I, Ohno T, Nayak R et al. Properties of retrovirus-like particles produced by a human breast carcinoma cell line: lmmunological relationship with mouse mammary virus proteins. Proc. Natl Acad. Sci. USA 1984; 81: 4188-4192.
117. Zangerle PF, Calberg-Bacq C-M, Colin C et al. Radioimmunoassay for glycoprotein gp47 of murine mammary tumor virus in organs and serum of mice and search for related antigen in human sera. Cancer Res. 1977; 37: 4326-4331.
118. Callahan R, Drohan W, Tronick S, Schlom J. Detection of cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proc. Natl Acad. Sci. USA 1982; 79: 5503-5507.
119. Axel R, Schlom J, Spiegelman S. Presence in human breast cancer of RNA homologous to mouse mammary tumor virus RNA. Nature 1972; 235: 32-36.
120. Crepin M, Lidereau R, Chermann JC, Pouillart P, Magdamenat H, Montaingnier L. Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer. Biochem. Biophys. Res. Commun. 1984; 118: 324-331.
121. Al-Sumldaic AM, Hart CA, Leinster SJ, Green CD. Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet 1988; 1: 5-8.
122. Westley BR, May FEB. The human genome contains multiple sequences of varying homology to mouse mammary tumor virus DNA. Gene 1984; 28: 221-227.
123. Ono M, Yasunaga T, Miyata T, Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J. Virol. 1986; 60: 589-598.
124. Faff O, Murray AB, Schmidt J, Leib-Mosch C, Erfle V. Hehlmann R. Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumor virus and are of endogenous origin. J. Gen. Virol. 1992; 73: 1087-1097.
125. Hareuveni M, Lathe R. Breast cancer sequences identified by mouse mammary tumor virus (MMTV) antiserum are unrelated to MMTV. Int. J. Cancer 1990; 46: 1134-1135.
126. May FEB, Westley BR. Characterization of sequences related to the mouse mammary tumor virus that are specific to MCF-7 breast cancer cells. Cancer Res. 1989; 49: 3879-3883.
127. Wang Y, Holland JF, Bleiweiss IJ et al. Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res. 1995; 5173-5179.
128. Casey G, Smith R, McGillivry D, Peters G, Dickson C. Characterization and chromosome assignment of the human homolog of int-2, a potential protooncogene. Mol. Cell Biol. 1986; 6: 502-510.
129. Lidereau R, Callahan R, Dickson C, Peters G, Escot C, Ali IU. Amplification of the int-2 gene in primary human breast tumors. Oncogene Res. 1988; 2: 285-291.
130. Zhou DJ, Casey G, Cline MJ. Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 1988; 2: 279-282.
131. Liscia DS, Merlo GR, Garrett C, French D, Marini-Constantini R, Callahan R. Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 1989; 4: 1219-1224.
132. Meyers SL, O'Brien MT, Smith T, Dudley JP. Analysis of the int-1, int-2, c-myc, and new oncogenes in human breast carcinomas. Cancer Res. 1990; 50: 5911-5918.
133. Schuwring E, Verhoeven E, van Tinteren H et al. Amplification of genes within chromosome 11q13 region is indicative of poor prognosis with operable breast cancer. Cancer Res. 1992; 52: 5229-5234.
134. Champeme M-H, Bieche I, Lizard S, Lidereau R. 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 1995; 12: 128-133.
135. Callahan R, Gallahan D, Smith D et al. Frequent mutations in breast cancer. Ann. N.Y. Acad. Sci. 1993; 3: 21-30.
136. Callahan R, Cropp D, Gallahan D et al. The genetic pathology of breast cancer. In: Klein-Szanto AJP, Barrett C, Anderson D, Slaga S, eds. Comparative Molecular Carcinogenesis. Wiley-Liss, New York, 1992; 117-136.